Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 4 3Phase 3 3Phase NA 1Phase EARLY_PHASE1 1Phase 1/2 1Phase 1 1

Status

Withdrawn 3Completed 3Unknown 1

Sponsor Class

OTHER 4INDUSTRY 3

Study Type

Interventional 7

Sponsor

Cancer Type

Dermatologic 3Lymphoid 2Thoracic 1Gynecologic 1Gastrointestinal 1

Conditions

Lymphoma, T-Cell, Cutaneous 2Vascular Malformations 1Uterine Cervical Dysplasia 1Pilonidal Sinus 1Pancreatic Neoplasms 1Mycosis Fungoides 1Keratosis, Actinic 1Hemangioma, Capillary 1Hemangioma 1Dermatitis, Contact 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 1514Carboplatin 1416Cyclophosphamide 1359Gemcitabine 1235Bevacizumab 1223Paclitaxel 1210Radiotherapy 1173Docetaxel 1079pembrolizumab 1026Oxaliplatin 934Capecitabine 898Fluorouracil 832Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 665Etoposide 660Irinotecan 622Leucovorin 574Pemetrexed 508Drug Therapy 491Cetuximab 481Trastuzumab 467Cytarabine 466Magnetic Resonance Spectroscopy 457Filgrastim 446Prednisone 432Lenalidomide 409Specimen Handling 407Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 2 × Ointments × Clear all
NCT03380026 2021-11-24

MIDAS

Rochester Skin Lymphoma Medical Group, PLLC

Phase 2 Completed
28 enrolled 8 charts
DermatologicLymphoid

Dermatitis, Contact, Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous

NCT04273997 2021-09-22

Metronidazole Ointment in Non-healing Pilonidal Sinus Wounds

S.L.A. Pharma AG

Phase 2 Unknown
80 enrolled

Pilonidal Sinus

NCT03083470 2019-05-15

Study of SOR007 Ointment for Actinic Keratosis

DFB Soria, LLC

Phase 2 Completed
33 enrolled 15 charts
Dermatologic

Keratosis, Actinic

NCT03143491 2017-10-18

Study of SOR007 Ointment for Cervical Intraepithelial Neoplasia (CIN)

DFB Soria, LLC

Phase 2 Withdrawn
Gynecologic

Uterine Cervical Dysplasia

NCT01843998 2015-06-04

Therapeutic Efficacy of Topical Sirolimus in Early Stage Cutaneous T-cell Lymphoma (CTCL)

Medical College of Wisconsin

Phase 2 Withdrawn
DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

NCT01593995 2014-11-04

EGF Ointment for Erlotinib Skin Lesion

Dong-A University Hospital

Phase 2 Completed
52 enrolled
GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Pancreatic Neoplasms

NCT01408056 2014-01-17

TOUCH

Children's Hospital of Philadelphia

Phase 2 Withdrawn

Hemangioma, Hemangioma, Capillary, Vascular Malformations

Data powered by HemOnc (CC BY 4.0) Colophon âš¡